- Home
- INO vs PHD Comparison
INO vs PHD Comparison
Compare INO & PHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- PHD
- Stock Information
- Founded
- INO 1979
- PHD 2004
- Country
- INO United States
- PHD United States
- Employees
- INO 134
- PHD N/A
- Industry
- INO Medical/Dental Instruments
- PHD Investment Managers
- Sector
- INO Health Care
- PHD Finance
- Exchange
- INO Nasdaq
- PHD Nasdaq
- Market Cap
- INO 128.1M
- PHD 123.5M
- IPO Year
- INO 1998
- PHD N/A
- Fundamental
- Price
- INO $2.37
- PHD $9.96
- Analyst Decision
- INO Buy
- PHD
- Analyst Count
- INO 5
- PHD 0
- Target Price
- INO $8.80
- PHD N/A
- AVG Volume (30 Days)
- INO 1.1M
- PHD 67.7K
- Earning Date
- INO 11-13-2025
- PHD 01-01-0001
- Dividend Yield
- INO N/A
- PHD 11.43%
- EPS Growth
- INO N/A
- PHD N/A
- EPS
- INO N/A
- PHD 1.27
- Revenue
- INO $182,337.00
- PHD N/A
- Revenue This Year
- INO N/A
- PHD N/A
- Revenue Next Year
- INO $15,960.33
- PHD N/A
- P/E Ratio
- INO N/A
- PHD $7.60
- Revenue Growth
- INO N/A
- PHD N/A
- 52 Week Low
- INO $1.30
- PHD $8.30
- 52 Week High
- INO $5.83
- PHD $9.81
- Technical
- Relative Strength Index (RSI)
- INO 54.07
- PHD 52.14
- Support Level
- INO $2.38
- PHD $9.93
- Resistance Level
- INO $2.58
- PHD $9.99
- Average True Range (ATR)
- INO 0.14
- PHD 0.03
- MACD
- INO -0.03
- PHD -0.00
- Stochastic Oscillator
- INO 51.95
- PHD 50.00
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About PHD Pioneer Floating Rate Fund Inc.
Pioneer Floating Rate Trust is a diversified, closed-end fund. It invests in the fixed income markets of the United States. The fund basically invests in senior secured floating-rate loans. It benchmarks the performance of its portfolio against the other High Yield Loans Index banks.